Cargando…

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial

BACKGROUND: The prevalence of myopia is increasing worldwide and is presently recognized as a major public health issue. Researchers and clinicians have been devoted in exploring appropriate clinical interventions to slow its progression in children. Mounting publications have proven that both ortho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ying, Zhu, Chengcheng, Liu, Mingming, Zhou, Yali, Yang, Xiao, Zheng, Bingru, Li, Zhouyue, Mao, Xinjie, Ke, Bilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633914/ https://www.ncbi.nlm.nih.gov/pubmed/34852833 http://dx.doi.org/10.1186/s13063-021-05825-1

Ejemplares similares

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
por: Du, Linlin, et al.
Publicado: (2023)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial
por: Yu, Shiao, et al.
Publicado: (2022)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
por: Yan, Chunxiao, et al.
Publicado: (2023)

Overnight orthokeratology is comparable with atropine in controlling myopia
por: Lin, Hui-Ju, et al.
Publicado: (2014)

Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial
por: Kinoshita, Nozomi, et al.
Publicado: (2020)

The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article)
por: Yu, Yan, et al.
Publicado: (2022)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Cui, Can, et al.
Publicado: (2021)

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
por: Chan, Henry H. L., et al.
Publicado: (2022)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2023)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia
por: Wan, Lei, et al.
Publicado: (2018)

Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
por: Yu, Manrong, et al.
Publicado: (2023)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
por: Joachimsen, Lutz, et al.
Publicado: (2021)

Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
por: Larkin, G. Luke, et al.
Publicado: (2019)

A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression
por: Kong, Xie-He, et al.
Publicado: (2021)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia
por: Sánchez-González, José-María, et al.
Publicado: (2020)

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
por: Cheng, Jingyi, et al.
Publicado: (2020)

Myopia control: short-term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses—a retrospective study in European children
por: Guimarães, Sandra, et al.
Publicado: (2023)

Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial
por: Zadnik, Karla, et al.
Publicado: (2023)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2022)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_amhs5krk7av91umgviv7jlcg2j